From: CD44 rs13347 C>T polymorphism predicts breast cancer risk and prognosis in Chinese populations
SNPs | Hazard ratio (95% CI) | P* | Breast cancer patients | Death | Log-rank P |
---|---|---|---|---|---|
Discovery Set | Â | Â | N= 566 | N= 63 | Â |
rs10836347 C>T | Â | Â | Â | Â | Â |
CC | 1.00 (Reference) | Â | 481 (85.0) | 55 | Â |
CT+TT | 0.89 (0.42 to 1.88) | 0.753 | 85 (15.0) | 8 | 0.5854 |
rs1425802 A>G | Â | Â | Â | Â | Â |
AA | 1.00 (Reference) | Â | 164 (29.0) | 24 | Â |
AG | 0.63 (0.37 to 1.09) | 0.102 | 276 (48.8) | 28 | 0.2274 |
GG | 0.73 (0.51 to 1.05) | 0.091 | 126 (22.2) | 11 | Â |
AG+GG | 0.61 (0.36 to 1.01) | 0.056 | 402 (71.0) | 39 | 0.0951 |
rs11821102 G>A | Â | Â | Â | Â | Â |
GG | 1.00 (Reference) | Â | 484 (85.5) | 54 | Â |
AG+AA | 0.93 (0.45 to 1.91) | 0.845 | 82 (14.5) | 9 | 0.973 |
rs713330 T>C | Â | Â | Â | Â | Â |
TT | 1.00 (Reference) | Â | 468 (82.7) | 51 | Â |
CT+CC | 1.14 (0.59 to 2.20) | 0.676 | 98 (17.3) | 12 | 0.6883 |
rs13347 C>T | Â | Â | Â | Â | Â |
CC | 1.00 (Reference) | Â | 255 (45.1) | 20 | Â |
CT | 1.36 (0.75 to 2.47) | 0.3189 | 223 (39.4) | 23 | 0.0004 |
TT | 3.18 (1.71 to 5.91) | 0.0003 | 88 (15.5) | 20 | Â |
CT+TT | 1.85 (1.09 to 3.15) | 0.0233 | 311 (54.9) | 43 | 0.0211 |
Validation Set | Â | Â | N = 331 | N = 62 | Â |
rs13347 C>T | Â | Â | Â | Â | Â |
CC | 1.00 (Reference) | Â | 200 (60.4) | 26 | Â |
CT | 2.10 (1.21 to 3.65) | 0.0081 | 100 (30.2) | 25 | 0.0012 |
TT | 3.14 (1.55 to 6.38) | 0.0015 | 31 (9.4) | 11 | Â |
CT+TT | 2.34 (1.41 to 3.88) | 0.0010 | 131 (39.6) | 36 | 0.0007 |
Pooled Analysis | Â | Â | N = 897 | N = 125 | Â |
rs13347 C>T | Â | Â | Â | Â | Â |
CC | 1.00 (Reference) | Â | 455 (50.7) | 46 | Â |
CT | 1.54 (1.02 to 2.30) | 0.0378 | 323 (36.0) | 48 | < 0.0001 |
TT | 2.84 (1.80 to 4.48) | < 0.0001 | 119 (13.3) | 31 | Â |
CT+TT | 1.87 (1.30 to 2.70) | 0.0007 | 442 (49.3) | 79 | 0.0006 |